Non-invasive measurement of blood glucose

• US 5,028,787 A
• Filed: 01/19/1989
• Issued: 07/02/1991
• Est. Priority Date: 01/19/1989
• Status: Expired due to Term

• Current Assignee: Futrex, Inc.
• Original Assignee: Futrex, Inc.
• Inventors: Rosenthal, Robert D., Paynter, Lynn N., Mackie, Linda H.
• Primary Examiner(s): Howell, Janice A.
• Assistant Examiner(s): Hanig, Richard
• Application Number:
  US07/298,904
• Time in Patent Office: 894 Days
• Field of Search: 250/339, 250/341, 250/343, 356/39, 128/633
• US Class Current: 250/339.12
• CPC Class Codes: A61B 5/0008 Temperature signals
• CPC Class Codes: A61B 5/14532 for measuring glucose, e.g. by tissue impedance measurement
• CPC Class Codes: A61B 5/1455 using optical sensors, e.g. spectral photometrical oximeters
• CPC Class Codes: G01N 21/314 with comparison of measurements at specific and non-specific wavelengths dual wavelength spectrometry G01J3/427

Abstract

A near-infrared quantitative analysis instrument and method non-invasively measures blood glucose by analyzing near-infrared energy following interactance with venous or arterial blood, or transmission through a blood containing body part. The instrument and method is accurate and can readily be utilized for at-home testing by diabetics.

Claims

1. A near-infrared quantitative analysis instrument for non-invasive measurement of blood glucose in blood present in a body part of a subject, comprising:

(a) means for introducing near-infrared energy into blood present in a body part of a subject;

(b) a near-infrared detector for detecting near-infrared energy within the range of about 600 to 1110 nanometers emerging from the body part and for providing a signal upon detection of near-infrared energy within said range emerging from the body part;

(c) means for positioning both the near-infrared introducing means and the near-infrared detector closely adjacent to the body part so that near-infrared energy detected by the detector corresponds to blood glucose level in said body part; and

(d) means for processing the signal produced by the detector into a second signal indicative of the quantity of glucose present in the blood of the subject.

2. An analysis instrument of claim 1 further including means for preventing near-infrared energy from the introducing means from impinging directly on the detector.

3. An analysis instrument of claim 2 wherein said introducing means includes a near-infrared energy source and transmitting means for transmitting said energy into the body part.

4. An analysis instrument of claim 3 wherein said source comprises at least one infrared emitting diode.

5. An analysis instrument of claim 3 wherein said transmitting means comprises a lens for focusing said energy onto the body part.

6. An analysis instrument of claim 2 wherein said processing means comprises amplifier means for amplifying the signal provided by said detector, and data processing means for converting the signal from the detector into said second signal.

7. An analysis instrument of claim 1 wherein said introducing means includes a near infrared source and a filter for selectively transmitting near-infrared energy which filter is disposed between said source and said body part.

8. An analysis instrument of claim 7 for blood glucose measurement wherein said filter selectively transmits near-infrared energy of between about 600 and about 1100 nanometers.

9. An analysis instrument of claim 1 wherein said introducing means provides a bandwidth centered on about 980 nanometers.

10. An analysis instrument of claim 1 wherein said positioning means includes means for marking a position for said instrument over a blood vessel of a subject.

11. An analysis instrument of claim 1 wherein said positioning means comprises means for positioning said introducing means closely adjacent to one side of the body part and for positioning said detector closely adjacent to a generally opposite side of the body part so that near-IR energy emitted by the introducing means is transmitted through said body part and detected by said detector.

12. An analysis instrument of claim 11 wherein the positioning means positions the introducing means and the detector on opposite sides of a finger.

13. An analysis instrument of claim 12 further including means for measuring the thickness of the body part and for providing a signal indicative of the thickness of the body part.

14. An analysis instrument of claim 13 wherein said means for providing a signal comprises a variable resistor.

15. An analysis instrument of claim 11 wherein said introducing means comprises at least one infrared emitting diode.

16. An analysis instrument of claim 11 wherein said introducing means provides a bandwidth centered on about 980 nanometers.

17. An analysis instrument of claim 11 wherein said introducing means includes a near infrared source and a filter for selectively transmitting near-infrared energy which filter is disposed between said source and said body part.

18. An analysis instrument of claim 17 for blood glucose measurement wherein said filter selectively transmits near-infrared energy of between about 600 and about 1100 nanometers.

19. The analysis instrument of claim 11 further including at least one filter for selectively transmitting near-infrared energy, which filter is disposed between the detector and said body part.

20. An analysis instrument of claim 19 for blood glucose measurement wherein said filter selectively transmits near-infrared energy of between about 600 and about 1100 nanometers.

22. The analysis instrument of claim 1 wherein said introducing means provides at least one wavelength pair centered on about 980 nanometers.

23. The analysis instrument of claim 1 wherein the signal processing means processes the signal according to the formula

24. The analysis instrument of claim 1 wherein the signal processing means processes the signal according to the formula

25. The analysis instrument of claim 1 wherein the signal processing means processes the signal according to the formula ##EQU2## wherein C is a concentration of glucose present in the blood, K₀ is an intercept constant, K₁ is line slope of ##EQU3## and log 1/I_G, log 1/I_H, log 1/I_I and log 1/I_J each represent an optical density value at corresponding wavelengths G, H, I and J.

26. The analysis instrument of claim 1 wherein the signal processing means processes the signal according to the formula ##EQU4## wherein C is concentration of glucose present in the blood, K₀ is an intercept constant, K₁ is line slope of ##EQU5## and log 1/I_A, log 1/I_B, log 1/I_C, log 1/I_D, log 1/I_E, and log 1/I_F each represent an optical density value at corresponding wavelengths A, B, C, D, E and F.

21. The method of claim 21 wherein near infrared energy centered on about 980 nanometers is introduced into the blood within said body part.

27. A non-invasive method for quantitatively analyzing blood glucose in blood of a subject, comprising:

(a) introducing at least one pair of wavelengths of near-infrared energy into blood within a body part of the subject, said pair being centered on a wavelength within the range of about 600 to 1100 nanometers;

(b) detecting near-infrared energy emerging from the subject with a detector which provides a signal upon detecting energy emerging from the subject, and

(c) processing the signal to provide a second signal indicative of the amount of glucose present in the blood of the subject.

28. The method of claim 27 wherein at least one pair of wavelengths of near infra-red energy centered on about 980 nanometers is introduced into the blood within said body part.

29. The method of claim 27 wherein the signal is processed according to the formula

30. The method of claim 27 wherein the signal processing means processes the signal according to the formula

31. The method of claim 27 wherein the signal processing means processes the signal according to the formula ##EQU6## wherein C is concentration of glucose present in the blood, K₀ is an intercept constant, K₁ is line slope of ##EQU7## and log 1/I_G, log 1/I_H, log 1/I_I and log 1/I_J each represent an optical density value at corresponding wavelengths G, H, I and J.

32. The method of claim 27 wherein the signal processing means processes the signal according to the formula ##EQU8## wherein C is concentration of glucose present in the blood, K₀ is an intercept constant, K₁ is line slope of ##EQU9## and log 1/I_A, log 1/I_B, log 1/I_C, log 1/I_D, log 1/I_E, and log 1/I_F each represent an optical density value at corresponding wavelengths A, B, C, D, E and F.